Core outcome set for preventive intervention trials in chronic and episodic migraine (COSMIG): an international, consensus-derived and multistakeholder initiative.

Kirstie L Haywood Rachel PotterRobert FroudGemma PearceBarbara BoxLynne MuldoonRichard LiptonStavros PetrouRegina Rendas-BaumAnne-Marie LoganKimberley StewartMartin UnderwoodManjit Matharunull null

Published in: BMJ open (2021)

International and multistakeholder consensus emerged to describe a two-domain core outcome set for reporting research on preventive interventions for chronic and episodic migraine: migraine-specific pain and migraine-specific quality of life. Intensity of migraine pain assessed with an 11-point Numerical Rating Scale and the frequency as the number of headache/migraine days over a specified time period. Migraine-specific quality of life assessed using the Migraine Functional Impact Questionnaire.

Keyphrases

chronic pain
randomized controlled trial
pain management
neuropathic pain
emergency department
spinal cord
quality improvement
high intensity
drug induced